SCHEMBL20429040

SCHEMBL20429040

CC(=O)N1c2ccc(-c3ccc(CCC(=O)NCCO)cc3)cc2CC[C@@H]1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.43
▸ BRD4 O60885 3/20 0.43
▸ BRD2 P25440 3/20 0.43
▸ BRD3 Q15059 3/20 0.43
▸ HTT P42858 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HRH3 Q9Y5N1 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ THRB P10828 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18871986 0.90 PDK1 (0.42) BRD4BRD2BRD3HTTALDH1A1
SCHEMBL18871760 0.84 MAPK1 (0.53) BRD4BRD2BRD3HTTALDH1A1
SCHEMBL18871776 0.84 NPC1 (0.44) BRD4BRD2BRD3HTTALDH1A1
SCHEMBL18871987 0.82 LMNA (0.49) CNR2HTTALDH1A1MEN1KMT2A
SCHEMBL14756003 0.82 BRD4 (0.53) BRD4BRD2BRD3HTTALDH1A1
SCHEMBL18871778 0.81 LMNA (0.42) BRD4BRD2BRD3HTTALDH1A1
SCHEMBL30366341 0.81 ALDH1A1 (0.45) BRD4BRD2BRD3HTTALDH1A1
SCHEMBL18872014 0.80 PDK1 (0.43) BRD4BRD2BRD3HTTALDH1A1
SCHEMBL26071758 0.79 BRD4 (0.45) BRD4BRD2BRD3HTTALDH1A1
SCHEMBL14755999 0.79 BRD4 (0.54) BRD4BRD2BRD3HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3168213-B1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE LLC (US) 2018-08-01 — — EP disclosed
Send feedback